Baker Hughes Officer Executes 10b5-1 Plan, Reduces Holdings to 20,349 Shares
Rhea-AI Filing Summary
James E. Apostolides, Chief Infra & Performance Officer of Baker Hughes Co (BKR), reported transactions on 09/23/2025 under a Rule 10b5-1 plan adopted 11/12/2024. He exercised 6,216 stock options with a $35.55 exercise price and simultaneously sold 6,216 shares at $50. After these transactions he beneficially owned 20,349 Class A shares. The option grant dated 01/22/2018 vested in three equal annual installments beginning one year after grant.
Positive
- Trade executed under a Rule 10b5-1 plan, indicating pre-scheduled compliance with insider trading rules
- Sale and exercise disclosed promptly, with attorney-in-fact signature confirming authorized filing
Negative
- Insider sold 6,216 shares, which represents a reduction in the reporting person's direct holdings to 20,349 shares
Insights
TL;DR: Officer exercised and sold 6,216 shares under a pre-existing 10b5-1 plan, reducing direct holdings to 20,349 shares.
The exercise at $35.55 and sale at $50 implies a realized pre-tax spread of $14.45 per share on 6,216 shares, consistent with routine option monetization under an established trading plan. This disclosure is orderly and compliant, providing transparency on insider liquidity without indicating company operational changes. The size of the sale appears modest relative to a large-cap issuer and is unlikely to be material to Baker Hughes' valuation.
TL;DR: Transactions executed pursuant to a Rule 10b5-1 plan; signature filed by attorney-in-fact confirms authorized execution.
The reporting notes the 10b5-1 plan adoption date and the attorney-in-fact signature, which are governance best practices for scheduled insider trades. The option grant vesting schedule from 2018 is disclosed, clarifying that these were vested, exercisable options rather than newly issued awards. No indication of accelerated grants, unusual related-party transactions, or amendments that would raise governance concerns.